Neurotech trends
This article was originally published in The Gray Sheet
Executive Summary
Micro/nano-electromechanical systems for monitoring and stimulating neuronal activitiy and noninvasive optical imaging instruments are among the innovations helping drive developments in neurotechnology, according to a 1report by NeuroInsights. The report, which examines the state of the neurotech industry, cites neuroimaging as a key emerging trend this year. In particular, advancements are being made in using imaging to diagnose and select treatment for psychiatric illness. According to NeuroInsights, sales in the neurodiagnostics sector, which includes products like magnetic resonance imaging and positron emission tomography devices, grew 3.7% in 2008 to $16.8 billion. Non-diagnostic neurodevice sales were up 18.6% in 2008 to $5.2 billion
You may also be interested in...
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.